C4C Expert Advice service gives you fast and efficient access to over 400 clinical, methodology, and patient and public involvement experts.

Their up-to-date and in-depth insights can provide value at any stage of paediatric drug development but are especially useful to improve study design.

We provide end-to-end support, resulting in high-quality, independent advice reports that can be used in regulatory discussions on PIPs (paediatric investigation plans) and PSPs (paediatric study plans )
Obtain multidisciplinary insights from a single request and a single contract.
A tailored team of experts is assembled for each request.
Improve patient recruitment and retention through making a study more patient-centric based on the insights of children, young people and families.